ACTORISE 200MG INJECTION
CIPLA LTD
PARENTERAL
In Stock
ACTORISE 200MG INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). ACTORISE 200MG INJECTION helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia.
ACTORISE 200MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. ACTORISE 200MG INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, ACTORISE 200MG INJECTION stimulates the production of this protein in the bone marrow.
ACTORISE 200MG INJECTION will be injected by the healthcare provider. Do not self-administer. The most common side effects of ACTORISE 200MG INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of ACTORISE 200MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking ACTORISE 200MG INJECTION to avoid any complications. Also, mention all the other medications you are taking to affect the way ACTORISE 200MG INJECTION works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to ACTORISE 200MG INJECTION.
Anaemia (in cancer and chronic kidney disease)
ACTORISE 200MG INJECTION is a human-made form of naturally occurring erythropoiesis-stimulating protein or erythropoietin (a hormone produced by the kidney's specialized cells and is responsible for protecting red blood cells against destruction and also stimulates the cells of bone marrow to produce more amount of red blood cells). Deficiency of erythropoietin happens when a person is suffering from chronic kidney diseases, which in turn cause low red blood cells count causing anaemia. This medicine is primarily indicated for treating anaemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells' cancer. ACTORISE 200MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells.
ACTORISE 200MG INJECTION can enhance the risk of serious heart problems including heart attack so tell your doctor immediately if you notice shortness of breath, sudden numbness or weakness, chest pain, or trouble speaking or understanding. This medicine may also shorten survival time in some people with certain types of cancer. Inform your doctor before taking ACTORISE 200MG INJECTION if you have heart disease, high blood pressure, kidney disease, stroke, heart attack, blood clot, seizure, or latex allergy. Do not take ACTORISE 200MG INJECTION if you are pregnant or breastfeeding unless prescribed by the doctor. ACTORISE 200MG INJECTION may affect a person's ability to drive as it may cause convulsion during initial days of treatment, so a person taking ACTORISE 200MG INJECTION should avoid driving or operating any machine. ACTORISE 200MG INJECTION should not be given to children below 12 years of age, as safety and effectiveness have not been established. Avoid consuming alcohol along with ACTORISE 200MG INJECTION as it could lead to increased dizziness and sleepiness.
Drug-Drug Interactions: ACTORISE 200MG INJECTION may have interaction with other chemotherapy drugs (thalidomide), immunosuppressant medication (cyclosporine), antihypertensive medicines (captopril).
Drug-Food Interactions: Avoid alcohol consumption while taking ACTORISE 200MG INJECTION as it might cause increased dizziness and sleepiness.
Drug-Disease Interactions: ACTORISE 200MG INJECTION may have interactions with disease conditions such as seizures, hemodialysis, hypertension, and thrombotic events
Avoid consumption of alcohol while taking ACTORISE 200MG INJECTION as it may increase dizziness and sleepiness.
Avoid taking ACTORISE 200MG INJECTION if you are pregnant unless prescribed by a doctor as ACTORISE 200MG INJECTION is a pregnancy category C drug. Please consult your doctor if you have any concerns regarding this, your doctor will prescribe only if the benefits outweigh the risks.
Consult your doctor before taking ACTORISE 200MG INJECTION; your doctor will decide whether ACTORISE 200MG INJECTION can be taken by breastfeeding mothers or not.
ACTORISE 200MG INJECTION causes convulsions (seizures), especially during the initial months of treatment. So, it is better not to drive or operate machinery unless you are alert.
Dose adjustment may be needed in patients with liver impairment. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Dose adjustment may be needed in patients with kidney impairment. Please consult your doctor if you have kidney impairment or any concerns regarding this.
ACTORISE 200MG INJECTION should not be given to children as the safety and efficacy have not been established.
This item is Not Returnable.
Expires on or after - Apr-24
Anaemia: It occurs when the body has a lower amount of red blood cells or haemoglobin than normal haemoglobin (iron-rich the protein responsible for allowing red blood cells to carry more oxygen from the lungs to the rest of the body). In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Symptoms of anaemia in chronic kidney disease include fatigue or tiredness, shortness of breath, ashen skin, weakness, body aches, chest pain, dizziness, fainting, fast or irregular heartbeat, headache, sleep problems, and trouble in concentrating.
India
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
MRP ₹13642.50
15%off(Inclusive of all taxes)
Provide Delivery Location
Vial
1 Injection in 1 Vial